Sound Pharma Gets Positive Data from Trial Treating Aminoglycoside-Induced Ototoxicity
Sound Pharmaceuticals will present the Phase 2b STOP Ototoxicity data at the Association for Research in Otolaryngology Midwinter Meeting.
Tag: ototoxic drugs
All
Latest
All
Latest
Frequency Therapeutics Supports HLAA Meeting on SNHL
Frequency Therapeutics, Inc, (Nasdaq: FREQ) shared a statement from David L. Lucchino, Frequency’s Chief Executive Officer, in support of the Hearing Loss Association of America (HLAA) and its efforts to advance the voice of the patient in leading “the first-ever Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on sensorineural hearing loss (SNHL).”
All
Latest
Purifying Gentamicin Could Reduce Hearing Loss Risk
Gentamicin is used in US hospitals to treat a variety of bacterial infections, including infections in newborns and in other susceptible patients, such as those with cystic fibrosis. Yet researchers estimate that up to 20% of patients who are treated with it experience some degree of irreversible hearing loss.
